Histone H3 covalent modifications driving response of BCR-ABL1+ cells sensitive and resistant to imatinib to Aurora kinase inhibitor MK-0457.
BRITISH JOURNAL OF HAEMATOLOGY（2012）
关键词
chronic myeloid leukaemia,BCR-ABL1,imatinib mesylate,Aurora kinase inhibitors,chromatin covalent modifications
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要